Skip to content

Dossier · BIRK · Dormant

BIRK · Birkenstock Holding plc · Stock research

Last analysed ·

Current thesis

Post-miss +46% V-recovery has rolled over — ~$44 from a ~$48.75 June high, never retesting the $53.53 ATH. The tell: fresh $500M buyback authority funded by the June 19 €900M notes landed and the stock still faded. S&P cut the outlook to negative and models EBITDA margin 28.5–29.0% vs the 30.0–30.5% guide. Aug 13 Q3 print is the binary.

Invalidation trigger

A weekly close below $43 loses the rising 20-EMA and the post-May recovery shelf, confirming the V-recovery has failed and that the up-to-$500M repurchase authority cannot defend the base; a lower high under $48.75 into the August 13 Q3 print keeps the structure a fading bounce.

Thesis status

Open commitment catalyst in 15dscored if the trigger above fires How this is scored →

Latest analysis and events for BIRK —

As of 2026-07-19, orbyd's latest analysis for Birkenstock Holding plc (BIRK): Post-miss +46% V-recovery has rolled over — ~$44 from a ~$48.75 June high, never retesting the $53.53 ATH. The tell: fresh $500M buyback authority funded by the June 19 €900M notes landed and the stock still faded. S&P cut the outlook to negative and models EBITDA margin 28.5–29.0% vs the 30.0–30.5% guide. Aug 13 Q3 print is the binary.

Invalidation trigger: A weekly close below $43 loses the rising 20-EMA and the post-May recovery shelf, confirming the V-recovery has failed and that the up-to-$500M repurchase authority cannot defend the base; a lower high under $48.75 into the August 13 Q3 print keeps the structure a fading bounce.

Next dated event on file: — catalyst in 15d.

« # BIRK — Birkenstock Holding plc

Current Thesis

The post-miss recovery leg is over and the tape is now grinding lower into a binary print. Birkenstock gapped down ~13% to the $33 handle on its May 13 Q2 FY2026 miss, then re-rated roughly +46% to ~$48.75 by mid-June on a $250M accelerated share repurchase, Kith collaboration heat, and short-covering. Since then the stock has bled back: ~$45.99 on July 2, ~$44.36 by July 17, roughly 9% below the June high and $9 under the $53.53 all-time high it never retested. The interesting wrinkle is that this fade happened with fresh buyback firepower in hand — the June 19 €900M 4.500% notes due 2033 explicitly earmarked up to $500M for additional repurchases. A stock that cannot hold a bid three weeks after management funds half a billion dollars of demand for its own float is telling you the marginal seller is larger than the mechanical buyer. The next dated event is the August 13 Q3 FY2026 print, and consensus targets ($51.75 average across 22 analysts) sit only ~17% above spot while two houses mark it at $41.

Bullish and bearish views on Birkenstock Holding plc

The model's bull view on Birkenstock Holding plc (BIRK), in brief: Constant-currency revenue grew +14% in Q2 FY2026 (reported +8%, May 13), with APAC +30% CC — the earnings miss traced to a ~640bps FX drag and incremental US tariffs, not unit demand. The bear view: S&P revised the outlook to negative from stable while affirming BB+, and its model runs below company guidance — adjusted EBITDA margin of 28.5–29.0% for 2026 versus the 30.0–30.5% guide. Both cases follow in full.

Bull Case

  • Constant-currency revenue grew +14% in Q2 FY2026 (reported +8%, May 13), with APAC +30% CC — the earnings miss traced to a ~640bps FX drag and incremental US tariffs, not unit demand.
  • FY2026 guidance reiterated May 13 and not walked down since: 13–15% CC revenue growth, €2.3–2.35B revenue, ≥€700M adjusted EBITDA, 30.0–30.5% EBITDA margin, adjusted EPS €1.90–2.05.
  • The June 19 refinancing is genuinely accretive to the P&L: €900M of 4.500% senior unsecured notes due 2033 redeem €428.5M of 5.25% notes due 2029, cutting the coupon and pushing the maturity wall out seven years.
  • Capital return authority is large relative to the ~184M-share float — the March $200M authorization, the $250M May ASR (Goldman, paid May 21, ~6M shares delivered against a $33.21 reference), and up to $500M more funded by the new notes. S&P models recurring buybacks of ~$200M/year.
  • Trailing fundamentals are still expanding: TTM revenue $2.52B (+11.5%), net income $409.9M (+40.9%), EPS $2.22 (+43.3%), at 19.98x trailing and 17.28x forward.
  • Fresh sell-side sponsorship: Raymond James initiated Outperform with a $52 target on July 1; Goldman carries Buy at $52.50; Zacks lifted the name off Strong Sell to Hold on July 2.

Bear Case

  • S&P revised the outlook to negative from stable while affirming BB+, and its model runs below company guidance — adjusted EBITDA margin of 28.5–29.0% for 2026 versus the 30.0–30.5% guide. When a rating agency underwrites the guide at a discount, the guide is the thing at risk.
  • Leverage is rising by design: S&P expects adjusted debt/EBITDA of ~3.0x in 2026 against 2.1x in 2025, with pro forma total indebtedness around €1,714.4M. The buyback is being funded with borrowed money into a margin-compression quarter.
  • Margin damage is showing at both lines. Q2 gross margin fell to 53.9% from 57.7% (380bps), adjusted EBITDA margin to 32.1% from 34.8%, with roughly 330bps attributed to tariffs and currency. Adjusted EPS declined year-on-year (€0.50 vs €0.55).
  • The +46% bounce was mechanically driven and the mechanism has now been tested. The $250M ASR settled ~June 30; the replacement authority landed June 19; the stock is nonetheless ~9% off the June high. Demand at $48 was thinner than the float shrinkage implied.
  • Insider distribution into the recovery: President EMEA Mehdi Nico Bouyakhf sold 90,000 shares June 5–8 (60,000 at ~$42.07, 30,000 at ~$43.50 weighted averages), leaving 31,153 shares held directly;
  • The bear marks are already live prices, not distant downside.

Setup & Price Structure

  • Spot ~$44.36 (July 17); 52-week range $31.12–$53.53; market cap ~$8.16B on ~184M shares.
  • The May-to-June move from the $33 handle to ~$48.75 completed a V and then failed roughly $5 short of the all-time high. Price has since rolled over through the early-July $46 area and is trending toward the low $40s.
  • ~$43 is the operative shelf — the level the rising 20-EMA and the recovery base converge on. Losing it on a weekly basis retires the recovery structure and re-opens the $38–41 air pocket back toward the May gap.
  • Overhead is layered: the ~$46 July pivot, the ~$48.75 June high, then $53.53. Three separate resistance shelves above a stock making lower highs is a poor risk skew for fresh money.
  • Beta near 1.25 with management having flagged Middle East demand risk on the call means any consumer-discretionary risk-off amplifies rather than dampens.
  • The August 13 print is 25 days out. Positioning ahead of a quarter where the central question — whether the 57.0–57.5% FY adjusted gross-margin guide holds against tariffs and FX — is unresolved is a coin-flip dressed as a setup. Better to let the number print and buy structure afterward.

Catalyst Calendar (next 30 days)

  • 2026-08-13 — Q3 FY2026 results (quarter ended June 30, 2026), released before US market open, conference call and webcast at 8:00 a.m. ET. The binary. Watch gross margin against the 57.0–57.5% FY guide, whether the 13–15% CC revenue growth and ≥€700M adjusted EBITDA guide survives, and how much of the $500M authority has actually been deployed since June 19.
  • Ongoing, no fixed date — repurchase activity under the up-to-$500M authority funded by the June 19 notes. Disclosure typically arrives with the quarterly filing rather than in real time, so the tape is the only live read on it.
  • Ongoing — US tariff policy and EUR/USD. Both were named as the direct cause of the Q2 miss; neither has a scheduled resolution date inside the window.
  • No PDUFA, no investor day, no index event, no lockup expiry scheduled in the next 30 days.

What Would Change Our Mind

  • A weekly close below $43 confirms the recovery leg has failed and the buyback bid cannot defend the base. That is the level that matters most.
  • Conversely, a weekly close back above $48.75 on expanding volume would re-establish higher highs and put the $53.53 ATH genuinely in play — that would flip the read from a fading bounce to a resumed uptrend.
  • On the August 13 print: a gross margin that holds the 57.0–57.5% FY guide with the CC growth range intact would validate the "FX and tariff optics, not demand" argument and make the current $44 handle look like the pullback entry the bulls are underwriting.
  • A guide-down on FY2026 EBITDA below €700M, or S&P moving from negative outlook to an actual downgrade, would confirm the margin pressure is structural and turn the leveraged buyback into a balance-sheet problem rather than a shareholder return.
  • Evidence of large, disclosed repurchase execution under the $500M authority that coincides with the stock reclaiming $46–48 would suggest the mechanical bid is working after all — the current read hinges on it visibly not working.

Correlation Notes

  • Trades as a premium-footwear and consumer-discretionary beta name. Read it alongside DECK and ON Holding as the closest listed comparables on brand-heat and international growth; Nike as the sector's macro proxy for wholesale channel health. Relative underperformance versus DECK/ONON into August would confirm the weakness is company-specific rather than sector-wide.
  • Directly exposed to EUR/USD translation — FX is a first-order driver here, not background noise.
  • Levered to US tariff headlines on European-manufactured consumer goods. Any tariff relief or escalation moves the margin story faster than any brand or product news.
  • As a BB+ credit with rising leverage and a fresh 2033 bond, the equity now carries some sensitivity to high-yield spreads. A risk-off widening in HY would pressure both the credit and the buyback capacity funding the equity story.
  • Low correlation to the AI and semiconductor complex that drives most of the current index tape, which cuts both ways: it will not participate in a mega-cap melt-up, and it will not be cushioned by one during a consumer scare. »

Notes

  • Q2 FY2026 reported May 13, 2026; the June 1 transcript republish is the same print, not a new event.
  • Next earnings Q3 FY2026 est. early-to-mid August 2026 — no earnings blackout inside the next 30 days.
  • $250M ASR (signed May 20) settles by ~June 30; the buyback bid that has helped float the +46% bounce disappears after settlement.
  • Rally is partly short-covering — treat sharp up-days as squeeze-amplified and size for two-way overshoot.
  • JPMorgan $82 target circulating in feeds looks stale versus the $50-55 cluster (Piper $50, Stifel $51) and current ~$49 tape — weight the median, not the outlier.
  • Next earnings Q3 FY2026 est. August 13, 2026 (quarter ended June 30) — outside the 30-day window as of July 4; no earnings blackout inside the next 30 days.
  • $250M Goldman ASR (paid May 21) settled ~June 30 — the buyback bid that floated the +46% bounce is gone; treat post-June-30 tape as no longer mechanically supported.
  • Q2 FY2026 was reported May 13, 2026; the June 1 transcript republish is the same print, not a new event.
  • Insider distribution: President EMEA Mehdi Nico Bouyakhf sold 90,000 shares June 5–8 (~$42.07 and ~$43.50); weight as a supply signal into the recovery.
  • Analyst targets cluster $51–52 (Raymond James $52, Goldman $52.50, avg $51.55, Strong Buy across 21); bear marks Morgan Stanley $41, Telsey $45. Any $80+ target still circulating in feeds is a stale outlier — weight the median, not the outlier.
  • Q3 FY2026 (quarter ended June 30) confirmed for 2026-08-13, before US market open, call 8:00 a.m. ET — earnings blackout window opens ~Aug 10 for a 3-trading-day rule.
  • June 19, 2026: €900M 4.500% senior unsecured notes due 2033 closed. Redeems €428.5M of 5.25% notes due 2029, funds up to $500M additional buybacks, pro forma total debt ~€1,714.4M. This SUPERSEDES the prior 'buyback bid is gone after ASR settlement' framing — the authority was replaced, not retired.
  • S&P revised outlook to NEGATIVE from stable, affirmed BB+ (issue rating BB+ on the 2033 notes, recovery 3). Models adjusted debt/EBITDA ~3.0x in 2026 vs 2.1x in 2025, and adj EBITDA margin 28.5–29.0% for 2026 — BELOW the company's own 30.0–30.5% guide. That gap is the single best bear datapoint on the name.
  • $250M Goldman ASR (signed May 20, paid May 21, ~6M shares against a $33.21 reference) settled ~June 30.
  • Insider distribution: President EMEA Mehdi Nico Bouyakhf sold 90,000 shares June 5–8 (~$42.07 and ~$43.50 weighted avg), leaving 31,153 shares direct;
  • Analyst target cluster $51–53.6 average; bears already at or below spot (Morgan Stanley $41, Deutsche Bank $41, Telsey $45 cut from $60). Raymond James initiated Outperform $52 on July 1. Any $80+ target circulating in feeds is a stale outlier — weight the median.
  • Price path to watch: $48.75 (June high) → $45.99 (Jul 2) → $44.36 (Jul 17). Sequence of lower highs; $43 is the operative shelf.

Related · shared themes

See also · stocks to watch